Drug Information

Drug General Information
Drug ID
D0I3IG
Former ID
DAP001243
Drug Name
Alseroxylon
Indication Hypertension [ICD9: 401; ICD10:I10-I16] Approved [550752]
Therapeutic Class
Antihypertensive Agents
Formula
C33H40N2O9
CAS Number
CAS 8001-95-4
Target and Pathway
Target(s) Synaptic vesicle amine transporter Target Info Blocker [536284]
KEGG Pathway Synaptic vesicle cycle
Serotonergic synapse
Dopaminergic synapse
Parkinson's disease
Cocaine addiction
Amphetamine addiction
Alcoholism
PANTHER Pathway Adrenaline and noradrenaline biosynthesis
5HT1 type receptor mediated signaling pathway
5HT2 type receptor mediated signaling pathway
5HT3 type receptor mediated signaling pathway
5HT4 type receptor mediated signaling pathway
Dopamine receptor mediated signaling pathway
Nicotine pharmacodynamics pathway
CCKR signaling map ST
Reactome Norepinephrine Neurotransmitter Release Cycle
Na+/Cl- dependent neurotransmitter transporters
WikiPathways Dopaminergic Neurogenesis
Synaptic Vesicle Pathway
Neurotransmitter Release Cycle
Nicotine Activity on Dopaminergic Neurons
References
Ref 550752Drug information of Alseroxylon, 2008. eduDrugs.
Ref 536284Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.